Social Pulse: GlaxoSmithKline PLC (GSK)
GSK on New York Consolidated
52.22USD
17 May 2013
52.22USD
17 May 2013
Price Change (% chg)
$0.11 (+0.21%)
$0.11 (+0.21%)
Prev Close
$52.11
$52.11
Open
$51.95
$51.95
Day's High
$52.29
$52.29
Day's Low
$51.81
$51.81
Volume
1,937,847
1,937,847
Avg. Vol
2,768,388
2,768,388
52-wk High
$52.65
$52.65
52-wk Low
$41.68
$41.68
- The Billion Dollar COPD Deal: Who Gains The Most?
- Complete Warren Buffett And Berkshire Hathaway 1st Quarter Portfolio Update
- Time To Show Optimism For Stocks
- Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q1 2013 Update
- Amicus Therapeutics: The Good And The Bad
- Aveo Screwed Up but Its Kidney Cancer Drug Is Real
Press Releases
- FDA Approves GlaxoSmithKline's four-strain seasonal influenza vaccine for use in the U.S.
- GSK receives FDA approval for raxibacumab anti-toxin for the treatment of inhalational anthrax
- GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
- FDA approves new indication for PROMACTA® (eltrombopag)
- GSK Responds to Hurricane Sandy Relief Needs
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
